Decision: Favourable
Study Title:
A PHASE III, MULTI-CENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GANTENERUMAB IN PARTICIPANTS AT RISK FOR OR AT THE EARLIEST STAGES OF ALZHEIMERS’S DISEASE
NREC Code:
22-NREC-CT-072
Decision:
Favourable
Meeting Date:
06/06/2022
Study Type:
CT application
Principal Investigator:
Professor Sean Kennelly
PI Institution:
Tallaght University Hospital
Sponsor:
Roche